Build a solid foundation in science, formulation and product development—find out more!
Most Popular in:
Patent Picks—Flavonoids, Genkwanin and Sakuranetin, Heat Shock Proteins and More
By: Rachel L. Grabenhofer
Posted: May 4, 2011
page 2 of 5
This invention describes a composition comprising a glyceryl salicylate compound and/or a glycol salicylate compound that can be used to reduce the amount of moisture evaporated from skin, protect the skin from UV light, and treat aged or damaged skin. The composition can be used in applications such as cosmetic skin care and can include an acid molecule attached to a glycerol or glycol molecule via an ester linkage.
Topical composition comprising n-acetyl glucosamine
European Patent Application EP2311452
Publication date: April 20, 2011
Assignee: RJ Yu and EJ Van Scott
This patent discloses compositions comprising N-acetyl-aidosamines, N-acetylamino acids and related N-acetyl compounds that are useful to alleviate or improve various cosmetic conditions and dermatological disorders, including changes or damage to skin, nail and hair associated with intrinsic aging and/or extrinsic aging, as well as changes or damage caused by extrinsic factors. N-acetyl-aldosamines, N-acetylamino acids, and related N-acetyl composition may further comprise a cosmetic, pharmaceutical or other topical agent to enhance or create synergetic effects.
Surfactant-free, water-free foamable compositions, breakable foams and gels and their uses
WIPO Patent Application WO/2011/039637
Publication date: April 7, 2011
Inventors: D Tamarkin, E Gazal, I Papiashvili, Y Hazot, D Schuz and R Keynan
This invention involves a substantially surface active agent-free composition that includes a hydrophobic solvent and/or a petrolatum, a paraffin wax and/or a fatty alcohol, a fatty acid and/or a wax and/or shea butter, with and without a propellant. A substantially surface active agent free composition further comprises a tetracycline antibiotic or a vitamin D derivative or one or more other active agents. A method of treatment using the composition also is disclosed.